Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - RESEARCH & DEVELOPMENT
Research & Development KYMR - Kymera Therapeutics, Inc.
189 M
LAST VALUE
17.47%
2 YEAR CAGR
60.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR